GlassScriptPhysician profile
Vrajesh Parmar
NPI 1023635711
$1,168.44
in general payments reported to CMS, 2019-2025
16 companies · $594 in 2025
The $594 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $575 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,168.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $292.14 | 2024 | Interstim |
| Glaxosmithkline, LLC. | $150.45 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $128.62 | 2024-2025 | Breztri, Farxiga |
| Novo Nordisk INC | $122.15 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $84.02 | 2024-2025 | Repatha, Repatha, Otezla |
| Abbvie INC. | $72.48 | 2024-2025 | |
| Astellas Pharma US INC | $72.17 | 2024-2025 | Veozah |
| Lilly USA, LLC | $64.48 | 2024-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $48.07 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $29.58 | 2024 | Spravato |
| Merck Sharp & Dohme LLC | $20.97 | 2025 | Gardasil 9, Capvaxive |
| Xeris Pharmaceuticals, INC. | $20.59 | 2025 | Gvoke Hypopen |
| Pfizer INC. | $17.05 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.06 | 2024 | Zoryve |
| Aimmune Therapeutics, INC. | $15.05 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.56 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vrajesh Parmar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.